CIGNA Update – A letter from MBCC’s Medical Adviser

Dear MBCC Supporter,

A new study has shown that adding 3-D mammography (tomosynthesis) or ultrasound found an additional 24 cancers in 3,000 women with dense breasts in whom conventional mammogram detected no abnormalities. This data was presented at the 10th European Breast Cancer Conference.

Breast density, defined as the relative amount of fibrous and glandular tissue to fat, can present difficulty when interpreting conventional mammography. It can “mask” abnormalities, including cancer. Additionally, some investigators believe increased breast density is a risk factor for cancer. Massachusetts law requires patients to be informed if they have dense breasts on routine screening mammograms.

This study adds to the growing body of evidence for the use of 3-D screening mammography. As Medical Adviser for Massachusetts Breast Cancer Coalition, I continue to apply pressure to Cigna Insurance to change their decision not to cover 3-D screening mammography. I forwarded this important study to their management team. I urge you to do the same.

It comes down to knowing your individual risk assessment. Discuss this with your doctor and determine what, if any, additional screening tests might be needed. Shared decision making with your doctor is crucial to good health. Be an informed patient. Use this opportunity to urge all insurance companies to cover 3-D mammography.

Sincerely,

Dr. Michael Misialek
Associate Chair of Pathology, Newton-Wellesley Hospital
Assistant Clinical Professor of Pathology, Tufts University School of Medicine
Medical Adviser, Massachusetts Breast Cancer Coalition